Scholars Central

Research articlePublished 17 Apr 2018

Neuroprotective Effect of Ginsenoside Rh1 on Scopolamine-Induced Cognitive Dysfunctions

Authors: Cong Lu Jingwei Lv, Liming Dong, Ning Jiang, Yan Wang, Bei Fan, Fengzhong Wang, Xinmin Liu

Neuropsychiatry

Volume 8 · Issue 2 · Pages 749–760

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Abstract Background : Ginsenoside Rh1, a 20(S)-protopanaxatriol with a single sugar moiety from ginseng, has benefits on the central nervous system and recently Rh1 had been reported to be effective for the Alzheimer’s disease (AD). Objective : The present study was conducted to investigate the neuroprotective effects of Ginsenoside Rh1 on scopolamine-induced cognitive dysfunctions and to elucidate its underlying mechanisms of action. Methods : Rh1 (20 and 40 μmol/kg) was administered intraperitoneally to mice for 28 days, and scopolamine (0.75 mg/kg) was injected intraperitoneally for 10 days to induce memory deficit. Memory-related behaviors were evaluated using object location recognition (OLR) experiment, novel object recognition (NOR) test, Morris water maze (MWM) test and passive avoidance (PA) task. Cholinergic system function and oxidative stress activities were measured in the hippocampus. The expression levels of CREB, Egr-1, c-Fos and c-Jun were also measured in the hippocampus. Results : Rh1 administration could improve the cognitive performance of scopolaminetreated mice in the object location recognition, the novel object recognition, the Morris water maze and the passive avoidance tests. And Rh1 significantly enhanced cholinergic system function and suppressed oxidative stress level in the hippocampus of scopolaminetreated mice, as indicated by decreasing acetylcholinesterase (AChE) activity, elevating choline acetyltransferase (ChAT) activity and acetylcholine (Ach) level, increasing superoxide dismutase (SOD) activity and lowering the level of malondialdehyde (MDA) in the hippocampus of scopolamine-treated mice. Moreover, for the first time, Rh1 was found to significantly upregulate the expression levels of CREB, early growth response-1 (Egr-1), c-Fos and c-Jun in the hippocampus of scopolamine-treated mice. Conclusion : These results demonstrated that Ginsenoside Rh1 might exert a significant neuroprotective effect on cognitive dysfunctions induced by scopolamine, driven in part by the modulation of cholinergic activity, oxidative stress level and upregulation of CREB, Egr-1, c-Fos and c-Jun expression in the hippocampus.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeuropsychiatry
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Cong Lu Jingwei Lv”
  • BylineArticles whose byline prints “Liming Dong”
  • BylineArticles whose byline prints “Ning Jiang”
  • BylineArticles whose byline prints “Yan Wang”
  • BylineArticles whose byline prints “Bei Fan”
  • BylineArticles whose byline prints “Fengzhong Wang”
  • BylineArticles whose byline prints “Xinmin Liu”